Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl

Monterrey, Mexico

Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl

Monterrey, Mexico

Time filter

Source Type

Bosques-Padilla F.J.,Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl | Vazquez-Elizondo G.,Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl | Villasenor-Todd A.,Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl | Gonzalez-Gonzalez J.A.,Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl | Maldonado-Garza H.J.,Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl
Annals of Hepatology | Year: 2010

Hepatitis C is a major public health issue. It infects about 200 million people worldwide and is a major cause of chronic liver disease. Its transmission in medical facilities is a topic of increased concern, as outbreaks of the disease had raised the attention of media and medical authorities. To date, evidence suggests that infection from in which a health-care worker is involved is mostly result of bad injecting practices as well as the result of shared medical devices. Furthermore, the infection caused by physicians is rare and very few well documented cases exist on the literature. Among countries, different definitions and legislation exist, in that mode that the responsibility of this issue almost is a an obligation of individual institutions. Nonetheless, Hepatitis C virus transmission in medical facilities is an important source of new cases, and as treatments options are very limited, its recommendable that institutions as well as governments implement policies to avoid Hepatitis C spread in a almost fully preventable setting.


Salazar-Riojas R.,Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl | Garcia-Lozano J.A.,Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl | Valdes-Galvan M.,Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl | Martinez-Gonzalez O.,Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl | And 6 more authors.
Journal of Clinical Apheresis | Year: 2015

Introduction: Peripheral blood stem cell (PBSC) transplantation has become a routine procedure in pediatric oncology. A special group of PBSC donors are children weighing 20 kg or less. Limited vascular access and low blood volume puts them at a higher risk. Central line placement and a priming apheresis machine are recommended to avoid these complications. Patients and Methods: PBSC collections performed from July 2006 to May 2013 in children weighing less than 20 kg were included. All donors had a central venous catheter (CVC). An apheresis machine was primed with packet red blood cells. Results: Twenty-seven PBSC collections were performed in 22 children weighing 20 kg or less, 14 for allogeneic and 8 for autologous transplantation, in order to collect at least 2 × 106 CD34+ cells/kg. In the allogeneic group, median age and weight were 3 years (0.8-7) and 15.5 kg (8-20). In the autologous group, median age and weight were 3 years (2-7) and 15.35 kg (12.5-19.5). A single large-volume apheresis was sufficient to obtain the CD34+ cells needed in 78.5% and 75% of the allogeneic and autologous groups, respectively, with a median 11.84 × 106 and 5.79 × 106 CD34+ cells collected per kilogram of weight of the recipient. No serious complications related to the apheresis procedure or CVC placement occurred. Conclusion: PBSC collection in a single large-volume apheresis for allogeneic and autologous transplants in children weighing 20 kg or less is a safe and effective procedure when based on standardized protocols. © 2015 Wiley Periodicals, Inc.


Garza-Rodriguez V.,Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl | De La Fuente-Garcia A.,Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl | Liy-Wong C.,Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl | Kury S.,Nantes University Hospital Center | And 3 more authors.
Pediatric Dermatology | Year: 2015

Acrodermatitis enteropathica (AE) is a rare disease that results from a defective gene, SLC39A4, and is characterized by dermatitis, alopecia, and diarrhea. We report a case of AE presenting with only periorificial and acral dermatitis in which genetic testing revealed two novel compound heterozygous missense mutations for SLC39A4. This case demonstrates that not all AE mutations alter zinc transporters in the same manner and highlights the phenotypic variability of AE. © 2015 Wiley Periodicals, Inc.


PubMed | Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl
Type: Journal Article | Journal: Hematology (Amsterdam, Netherlands) | Year: 2013

Imatinib has been considered as the gold standard for drug therapy of chronic myelogenous leukemia (CML) because it offers higher cytogenetic response and better quality of life than traditional drugs. In this study we applied the standard 400 mg dose of imatinib in 37 CML Ph (+) Mexican patients, monitoring their cytogenetic response using fluorescent in situ hybridization and carrying out molecular analyses using reverse transcription polymerase chain reaction. The study included 19 male and 18 female patients with a median age of 41 years. The median follow-up time from diagnosis was 56 months. Thirty-six patients (97%) achieved complete hematologic response in a median time of 29 days. Complete cytogenetic response and complete molecular remission was observed in only five (13%) and three (8.1%) patients, respectively, less than the expected rate (50-90%) reported in other studies.


PubMed | Risk Based Decisions Inc., Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl and Nantes University Hospital Center
Type: Case Reports | Journal: Pediatric dermatology | Year: 2015

Acrodermatitis enteropathica (AE) is a rare disease that results from a defective gene, SLC39A4, and is characterized by dermatitis, alopecia, and diarrhea. We report a case of AE presenting with only periorificial and acral dermatitis in which genetic testing revealed two novel compound heterozygous missense mutations for SLC39A4. This case demonstrates that not all AE mutations alter zinc transporters in the same manner and highlights the phenotypic variability of AE.

Loading Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl collaborators
Loading Hospital Universitario Dr Jose Eleuterio Gonzalez Uanl collaborators